Market News Research Screener Watchlist

RLMD Relmada Therapeutics, Inc.

Healthcare

$7.04-2.36%ClosedMarket Cap: $516.3M

As of 2026-05-25

Overview Financials Analyst Insider Congress ETF & Holdings Dividends Earnings Comments

No congress trading data available for RLMD.

Data provided for informational purposes only. Not financial advice.

© 2026 InvestLog AI